Table 1. - Distribution of the study participants according to clinical and therapeutic variables. Ribeirão Preto, SP, Brazil, 2013.
| Variables | n | % | |
|---|---|---|---|
| Number of medications | |||
| One medication | 106 | 94.64 | |
| More than one medication | 6 | 5.36 | |
| ATC Classification | |||
| Alkylating agents (L01A) | 2 | 1.78 | |
| Antimetabolites (L01B) | 1 | 0.89 | |
| Plant alkaloids and other natural products (L01C) | 2 | 1.78 | |
| Cytotoxic antibiotics and related substances (L01D) | 2 | 1.78 | |
| Other anticancer agents (L01X) | 1 | 0.89 | |
| Hormones antagonists and related agents (L02B) | 110 | 98.21 | |
| Number of surgeries | |||
| Up to one surgery | 65 | 58.04 | |
| More than one surgery | 47 | 41.96 | |
| Time since diagnosis | |||
| 1 – 30 months | 56 | 50.00 | |
| 31 – 144 months | 56 | 50.00 | |
| Total | 112 | 100.00 | |